Clinical Research Directory
Browse clinical research sites, groups, and studies.
DBS TaT in Peer-assisted Telemedicine for Hepatitis C
Sponsor: Oregon Health and Science University
Summary
The purpose of this study is to compare the rate of treatment initiation achieved by peer-assisted telemedicine contingent on phlebotomy (usual care) versus that achieved with a new protocol, called Dried Blood Spot Test and Treat (DBS TaT). DBS TaT includes DBS testing to diagnose hepatitis C (HCV), utilizes a novel clinical decision aid that identifies patients who are low risk for hepatic (liver) fibrosis, and directs those patients to HCV treatment initiation prior to routine hepatic fibrosis assessment. The investigators hypothesize that DBS TaT will increase the rate of HCV treatment initiation compared to peer-assisted telemedicine contingent on phlebotomy (usual care).
Official title: Dried Blood Spot Testing in Peer-assisted Telemedicine for Hepatitis C Treatment
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
141
Start Date
2025-01-22
Completion Date
2026-05
Last Updated
2025-03-06
Healthy Volunteers
No
Conditions
Interventions
DBS TaT
Dried Blood Spot (DBS) testing for HCV DCHEQ and Baseline Surveys If at high risk for liver fibrosis, blood draw prior to treatment initiation If low risk for liver fibrosis, Telemedicine visit with PATHS provider HCV treatment initiation Transient elastography (TEG)
Usual Care
Point-of-care or DBS testing for HCV Blood draw to test liver fibrosis DCHEQ and Baseline Surveys Telemedicine visit with PATHS provider HCV treatment initiation Transient elastography (TEG)
Locations (1)
Oregon Health & Science University
Portland, Oregon, United States